Chronic rhinosinusitis (CRS) is a surprisingly common but under-recognized disease that affects nearly one billion people ...

The first head-to-head randomized clinical trial to compare biologics in severe chronic rhinosinusitis with nasal polyps ...

New research from BIDMC and Stanford reveals how nasal polyps form in chronic sinusitis, offering hope for improved care and treatment options. Read more.

Tezspire (tezepelumab) has received a positive opinion from the CHMP for the treatment of chronic rhinosinusitis with nasal ...

Scientists Uncover the "Cellular Conspiracy" Behind Chronic Sinus DiseaseBOSTON — Chronic rhinosinusitis (CRS) is a surprisingly common but ...

While colorectal cancer polyps often have no symptoms—especially in the early stages—there are some warning signs to be on the lookout for...plus one common myth about polyps.

​Amgen Inc. (NASDAQ: AMGN) is one of the Most Undervalued Growth Stocks to Buy According to Hedge Funds. On September 22, ...

Many patients attribute these symptoms to frequent “colds”. They may be prescribed antibiotics and other symptomatic ...

AstraZeneca and Amgen’s Tezspire (tezepelumab) has been recommended for approval in the European Union (EU) for the treatment of adult patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

AstraZeneca and Amgen secure CHMP support for Tezspire in nasal polyps and Koselugo in neurofibromatosis after strong Phase 3 ...

Cambridge: AstraZeneca and Amgen's Tezspire (tezepelumab) has been recommended for approval in the European Union (EU) for ...

A new study reveals that popular low-carb, low-fiber diets may significantly increase the risk of colorectal cancer, ...